PMID: 9658074Jul 11, 1998Paper

Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells

Journal of Virology
C A Pise-MasisonJ N Brady

Abstract

Inhibition of p53 function, through either mutation or interaction with viral or cellular transforming proteins, correlates strongly with the oncogenic potential. Only a small percentage of human T-cell lymphotropic virus type 1 (HTLV-1)-transformed cells carry p53 mutations, and mutated p53 genes have been found in only one-fourth of adult T-cell leukemia cases. In previous studies, we demonstrated that wild-type p53 is stabilized and transcriptionally inactive in HTLV-1-transformed cells. Further, the viral transcriptional activator Tax plays a role in both the stabilization and inactivation of p53 through a mechanism involving the first 52 amino acids of p53. Here we show for the first time that phosphorylation of p53 inactivates p53 by blocking its interaction with basal transcription factors. Using two-dimensional peptide mapping, we demonstrate that peptides corresponding to amino acids 1 to 19 and 387 to 393 are hyperphosphorylated in HTLV-1-transformed cells. Moreover, using antibodies specific for phosphorylated Ser15 and Ser392, we demonstrate increased phosphorylation of these amino acids. Since HTLV-1 p53 binds DNA in a sequence-specific manner but fails to interact with TFIID, we tested whether phosphorylation of t...Continue Reading

References

Apr 1, 1992·Nature Genetics·W S el-DeiryB Vogelstein
Nov 27, 1992·Cell·T R HuppD P Lane
Jun 1, 1992·Molecular and Cellular Biology·W D FunkJ W Shay
Dec 1, 1991·Japanese Journal of Cancer Research : Gann·H NagaiM Shimoyama
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W E MercerS J Ullrich
Nov 1, 1990·Molecular and Cellular Biology·L DillerB Vogelstein
Sep 1, 1990·Annals of the Rheumatic Diseases·S IjichiM Osame
Oct 1, 1989·The British Journal of Ophthalmology·K SasakiM Osame
May 3, 1986·Lancet·M OsameM Tara
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszR C Gallo
Jun 1, 1995·Nature Genetics·X W WangB G Taffe
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·H Lu, A J Levine
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J A PietenpolB Vogelstein
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·S J UllrichE Appella
Sep 2, 1993·Nature·A DuttaE Winchester
May 1, 1996·Genes & Development·L J Ko, C Prives
Oct 25, 1996·Journal of Molecular Biology·W T SteegengaA G Jochemsen
Jun 19, 1997·Nature·W GuR G Roeder
Jun 19, 1997·Nature·N L LillD M Livingston
Jun 27, 1997·Cell·M L AvantaggiatiK Kelly
Feb 7, 1998·Genes & Development·J D SilicianoM B Kastan

❮ Previous
Next ❯

Citations

Feb 18, 1999·Molecular and Cellular Biology·M AshcroftK H Vousden
May 29, 2003·Oncogene·Nicole SchneiderhanBernhard Brüne
Jun 1, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Takahiro TsujiTakashi Yoshiki
Sep 13, 2005·Oncogene·Shao-Cong Sun, Shoji Yamaoka
Dec 2, 2008·Nature Reviews. Drug Discovery·Anwesha DeyDavid P Lane
Jul 26, 2002·Molecular and Cellular Biology·Yaron DanielyJames A Borowiec
Mar 13, 2001·Annual Review of Immunology·M Yoshida
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sohail ChaudhryKevin Gardner
Oct 3, 1999·Current Opinion in Oncology·E Cesarman, E A Mesri
Sep 19, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Francien H van NederveenWinand N M Dinjens
Mar 28, 2008·Journal of Cellular Physiology·Tajhal Dayaram, Susan J Marriott
Oct 30, 2008·The Journal of Biological Chemistry·Sarah S DurkinO John Semmes
Jun 10, 2019·European Journal of Nutrition·Yasir I Mohammed SaleemMustafa Selim
May 26, 1999·The Journal of Pathology·C Prives, P A Hall
Nov 26, 1998·The Journal of Biological Chemistry·P F LambertJ N Brady
Nov 18, 2000·AIDS Research and Human Retroviruses·R MahieuxJ N Brady
Dec 19, 2002·Journal of Peptide Science : an Official Publication of the European Peptide Society·Gyorgyi Varadi, Laszlo Otvos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.